14520145

Source:http://linkedlifedata.com/resource/pubmed/id/14520145

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205488, umls-concept:C0663241, umls-concept:C0728836, umls-concept:C1280500
pubmed:issue	9 Suppl
pubmed:dateCreated	2003-10-1
pubmed:abstractText	Linezolid is an effective and well-tolerated antibiotic for the treatment of Gram-positive infections, including hospital and community-acquired pneumonia and complicated and uncomplicated skin and skin structure infections. In adults linezolid treatment for >/=2 weeks has been associated with reversible hematopoietic suppression, primarily thrombocytopenia.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8701858
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acetamides, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins, http://linkedlifedata.com/resource/pubmed/chemical/Oxazolidinones, http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin, http://linkedlifedata.com/resource/pubmed/chemical/linezolid
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0891-3668
pubmed:author	pubmed-author:BrussJon BJB, pubmed-author:Edge-PadburyBarbaraB, pubmed-author:KaplanSheldon LSL, pubmed-author:MeissnerH CodyHC, pubmed-author:MorfinMaria RayoMR, pubmed-author:Naberhuis-StehouwerSharonS, pubmed-author:TownsendTimothyT, pubmed-author:WenmanWandaW
pubmed:issnType	Print
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S186-92
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:14520145-Acetamides, pubmed-meshheading:14520145-Administration, Oral, pubmed-meshheading:14520145-Age Factors, pubmed-meshheading:14520145-Anemia, pubmed-meshheading:14520145-Anti-Bacterial Agents, pubmed-meshheading:14520145-Anti-Infective Agents, pubmed-meshheading:14520145-Child, pubmed-meshheading:14520145-Child, Preschool, pubmed-meshheading:14520145-Female, pubmed-meshheading:14520145-Gram-Positive Bacterial Infections, pubmed-meshheading:14520145-Hemoglobins, pubmed-meshheading:14520145-Humans, pubmed-meshheading:14520145-Infant, pubmed-meshheading:14520145-Infant, Newborn, pubmed-meshheading:14520145-Infusions, Intravenous, pubmed-meshheading:14520145-Male, pubmed-meshheading:14520145-Neutropenia, pubmed-meshheading:14520145-Oxazolidinones, pubmed-meshheading:14520145-Thrombocytopenia, pubmed-meshheading:14520145-Vancomycin
pubmed:year	2003
pubmed:articleTitle	Hematologic effects of linezolid in young children.
pubmed:affiliation	Pediatric Infectious Diseases, New England Medical Center, Tufts University School of Medicine, 750 Washington Street, NEMCH Box 321, Boston, MA 02111, USA. CMeissner@tufts-nemc.org
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study